Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares Repurchased
Ratios

Cross Country Healthcare (CCRN) Depreciation & Amortization (IS) (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Depreciation & Amortization (IS) for 10 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (IS) fell 11.7% year-over-year to $3.8 million, compared with a TTM value of $16.8 million through Dec 2025, down 7.73%, and an annual FY2025 reading of $16.8 million, down 7.73% over the prior year.
  • Depreciation & Amortization (IS) was $3.8 million for Q4 2025 at Cross Country Healthcare, down from $4.1 million in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $4.9 million in Q1 2023 and bottomed at $2.2 million in Q2 2021.
  • Average Depreciation & Amortization (IS) over 5 years is $3.8 million, with a median of $4.1 million recorded in 2025.
  • The sharpest move saw Depreciation & Amortization (IS) plummeted 44.03% in 2021, then soared 80.36% in 2023.
  • Year by year, Depreciation & Amortization (IS) stood at $2.7 million in 2021, then grew by 16.25% to $3.2 million in 2022, then surged by 41.4% to $4.5 million in 2023, then decreased by 2.91% to $4.3 million in 2024, then dropped by 11.7% to $3.8 million in 2025.
  • Business Quant data shows Depreciation & Amortization (IS) for CCRN at $3.8 million in Q4 2025, $4.1 million in Q3 2025, and $4.1 million in Q2 2025.